# Universal Insurance Holdings, Inc.: financial statements, quarterly

UVE · NYSE · CIK 891166 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/uve.md) · [Financials](/companies/uve/financials.md) · [Filings](/companies/uve/filings.md) · [Insiders](/companies/uve/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/uve/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [375](/filings/0000891166-25-000025.md) | [368](/filings/0000891166-26-000010.md) | [380](/filings/0000891166-26-000010.md) | [388](/filings/0000891166-26-000010.md) | [385](/filings/0000891166-26-000010.md) | [395](/filings/0000891166-26-000046.md) | [400](/filings/0000891166-26-000088.md) | [401](/filings/0000891166-26-000094.md) | [408](/filings/0000891166-26-000010.md) | [394](/filings/0000891166-26-000046.md) | [427](/filings/0000891166-26-000088.md) | [439](/filings/0000891166-26-000094.md) |
| Selling, general and administrative | $m | [73.1 d](/filings/0000891166-25-000025.md) | [78.7](/filings/0000891166-25-000058.md) | [87.1](/filings/0000891166-24-000075.md) | [87.1](/filings/0000891166-24-000094.md) | [89.2 d](/filings/0000891166-25-000025.md) | [87.2](/filings/0000891166-25-000058.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [1.6 d](/filings/0000891166-24-000013.md) | [1.6](/filings/0000891166-24-000027.md) | [1.6](/filings/0000891166-24-000075.md) | [1.6](/filings/0000891166-24-000094.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [5.9 d](/filings/0000891166-26-000010.md) | [13.8](/filings/0000891166-25-000058.md) | [12.5](/filings/0000891166-25-000130.md) | [(2.0)](/filings/0000891166-25-000174.md) | [1.3 d](/filings/0000891166-26-000010.md) | [14.0](/filings/0000891166-26-000046.md) | [11.3](/filings/0000891166-26-000088.md) | [12.9](/filings/0000891166-26-000094.md) | [21.9 d](/filings/0000891166-26-000010.md) | [17.4](/filings/0000891166-26-000046.md) | [20.4](/filings/0000891166-26-000088.md) | [17.6](/filings/0000891166-26-000094.md) |
| Net income | $m | [20.0](/filings/0000891166-25-000025.md) | [33.7](/filings/0000891166-26-000010.md) | [35.4](/filings/0000891166-26-000010.md) | [(16.2)](/filings/0000891166-26-000010.md) | [6.0](/filings/0000891166-26-000010.md) | [41.4](/filings/0000891166-26-000094.md) | [35.1](/filings/0000891166-26-000094.md) | [39.8](/filings/0000891166-26-000094.md) | [66.6](/filings/0000891166-26-000010.md) | [54.3](/filings/0000891166-26-000094.md) | [59.2](/filings/0000891166-26-000094.md) | [52.5](/filings/0000891166-26-000094.md) |
| Diluted EPS | $ per share | [0.68](/filings/0000891166-25-000025.md) | [1.14](/filings/0000891166-26-000010.md) | [1.21](/filings/0000891166-26-000010.md) | [(0.57)](/filings/0000891166-26-000010.md) | [0.21](/filings/0000891166-26-000010.md) | [1.44](/filings/0000891166-26-000046.md) | [1.21](/filings/0000891166-26-000088.md) | [1.38](/filings/0000891166-26-000094.md) | [2.28](/filings/0000891166-26-000010.md) | [1.88](/filings/0000891166-26-000046.md) | [2.04](/filings/0000891166-26-000088.md) | [1.80](/filings/0000891166-26-000094.md) |
| Basic EPS | $ per share | [0.69](/filings/0000891166-25-000025.md) | [1.17](/filings/0000891166-26-000010.md) | [1.24](/filings/0000891166-26-000010.md) | [(0.57)](/filings/0000891166-26-000010.md) | [0.21](/filings/0000891166-26-000010.md) | [1.48](/filings/0000891166-26-000046.md) | [1.25](/filings/0000891166-26-000088.md) | [1.43](/filings/0000891166-26-000094.md) | [2.40](/filings/0000891166-26-000010.md) | [1.96](/filings/0000891166-26-000046.md) | [2.14](/filings/0000891166-26-000088.md) | [1.90](/filings/0000891166-26-000094.md) |

- Revenue: us-gaap:Revenues
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [397](/filings/0000891166-26-000010.md) | [396](/filings/0000891166-24-000027.md) | [283](/filings/0000891166-24-000075.md) | [334](/filings/0000891166-24-000094.md) | [259](/filings/0000891166-26-000010.md) | [398](/filings/0000891166-25-000058.md) | [367](/filings/0000891166-25-000130.md) | [405](/filings/0000891166-25-000174.md) | [409](/filings/0000891166-26-000094.md) | [596](/filings/0000891166-26-000046.md) | [532](/filings/0000891166-26-000088.md) | [569](/filings/0000891166-26-000094.md) |
| Total assets | $m | [2,317](/filings/0000891166-25-000025.md) | [2,120](/filings/0000891166-24-000027.md) | [2,679](/filings/0000891166-24-000075.md) | [2,651](/filings/0000891166-24-000094.md) | [2,842](/filings/0000891166-26-000010.md) | [2,715](/filings/0000891166-25-000058.md) | [3,276](/filings/0000891166-25-000130.md) | [3,090](/filings/0000891166-25-000174.md) | [2,840](/filings/0000891166-26-000094.md) | [2,769](/filings/0000891166-26-000046.md) | [3,306](/filings/0000891166-26-000088.md) | [3,184](/filings/0000891166-26-000094.md) |
| Total liabilities | $m | [1,975](/filings/0000891166-25-000025.md) | [1,755](/filings/0000891166-24-000027.md) | [2,285](/filings/0000891166-24-000075.md) | [2,250](/filings/0000891166-24-000094.md) | [2,469](/filings/0000891166-26-000010.md) | [2,292](/filings/0000891166-25-000058.md) | [2,818](/filings/0000891166-25-000130.md) | [2,595](/filings/0000891166-25-000174.md) | [2,289](/filings/0000891166-26-000094.md) | [2,185](/filings/0000891166-26-000046.md) | [2,669](/filings/0000891166-26-000088.md) | [2,538](/filings/0000891166-26-000094.md) |
| Long-term debt | $m | [102](/filings/0000891166-25-000025.md) | [102](/filings/0000891166-24-000027.md) | [102](/filings/0000891166-24-000075.md) | [101](/filings/0000891166-24-000094.md) | [101](/filings/0000891166-26-000010.md) | [101](/filings/0000891166-25-000058.md) | [101](/filings/0000891166-25-000130.md) | [101](/filings/0000891166-25-000174.md) | [100](/filings/0000891166-26-000094.md) | [100](/filings/0000891166-26-000046.md) | [97.9](/filings/0000891166-26-000088.md) | [97.3](/filings/0000891166-26-000094.md) |
| Shareholders' equity | $m | [341](/filings/0000891166-26-000010.md) | [365](/filings/0000891166-25-000174.md) | [393](/filings/0000891166-25-000174.md) | [400](/filings/0000891166-25-000174.md) | [373](/filings/0000891166-26-000094.md) | [422](/filings/0000891166-26-000094.md) | [458](/filings/0000891166-26-000094.md) | [495](/filings/0000891166-26-000094.md) | [551](/filings/0000891166-26-000094.md) | [585](/filings/0000891166-26-000094.md) | [637](/filings/0000891166-26-000094.md) | [646](/filings/0000891166-26-000094.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [0.3 d](/filings/0000891166-26-000010.md) | [82.9](/filings/0000891166-25-000058.md) | [73.2 d](/filings/0000891166-25-000130.md) | [82.6 d](/filings/0000891166-25-000174.md) | [(101) d](/filings/0000891166-26-000010.md) | [187](/filings/0000891166-26-000046.md) | [106 d](/filings/0000891166-26-000088.md) | [62.4 d](/filings/0000891166-26-000094.md) | [26.1 d](/filings/0000891166-26-000010.md) | [155](/filings/0000891166-26-000046.md) | [101 d](/filings/0000891166-26-000088.md) | [83.0 d](/filings/0000891166-26-000094.md) |
| Capital expenditure | $m | [1.2 d](/filings/0000891166-26-000010.md) | [3.3](/filings/0000891166-25-000058.md) | [1.5 d](/filings/0000891166-25-000130.md) | [1.7 d](/filings/0000891166-25-000174.md) | [0.9 d](/filings/0000891166-26-000010.md) | [1.2](/filings/0000891166-26-000046.md) | [1.0 d](/filings/0000891166-26-000088.md) | [1.2 d](/filings/0000891166-26-000094.md) | [1.1 d](/filings/0000891166-26-000010.md) | [1.6](/filings/0000891166-26-000046.md) | [0.9 d](/filings/0000891166-26-000088.md) | [1.1 d](/filings/0000891166-26-000094.md) |
| Dividends paid | $m | [8.6 d](/filings/0000891166-26-000010.md) | [4.6](/filings/0000891166-25-000058.md) | [4.6 d](/filings/0000891166-25-000130.md) | [4.5 d](/filings/0000891166-25-000174.md) | [8.5 d](/filings/0000891166-26-000010.md) | [4.8](/filings/0000891166-26-000046.md) | [4.5 d](/filings/0000891166-26-000088.md) | [4.5 d](/filings/0000891166-26-000094.md) | [8.4 d](/filings/0000891166-26-000010.md) | [4.9](/filings/0000891166-26-000046.md) | [4.4 d](/filings/0000891166-26-000088.md) | [4.5 d](/filings/0000891166-26-000094.md) |
| Share repurchases | $m | [3.6 d](/filings/0000891166-26-000010.md) | [4.5](/filings/0000891166-25-000058.md) | [5.3 d](/filings/0000891166-25-000130.md) | [4.4 d](/filings/0000891166-25-000174.md) | [7.7 d](/filings/0000891166-26-000010.md) | [0.0](/filings/0000891166-26-000046.md) | [7.4 d](/filings/0000891166-26-000088.md) | [8.1 d](/filings/0000891166-26-000094.md) | [6.9 d](/filings/0000891166-26-000010.md) | [7.1](/filings/0000891166-26-000046.md) | [4.5 d](/filings/0000891166-26-000088.md) | [7.5 d](/filings/0000891166-26-000094.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [30.6](/filings/0000891166-24-000027.md) | [30.7](/filings/0000891166-24-000075.md) | [29.6](/filings/0000891166-24-000094.md) | [29.4](/filings/0000891166-25-000058.md) | [29.3](/filings/0000891166-25-000130.md) | [28.4](/filings/0000891166-25-000174.md) | [28.8](/filings/0000891166-26-000046.md) | [29.1](/filings/0000891166-26-000088.md) | [28.8](/filings/0000891166-26-000094.md) | [28.8](/filings/0000891166-26-000046.md) | [29.0](/filings/0000891166-26-000088.md) | [29.2](/filings/0000891166-26-000094.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 27,670,206 at 2026-10-26, from the cover of the [10-Q filed 2026-10-29](/filings/0000891166-26-000094.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 18:13 ET. No prices; not investment advice.